NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.
Saved in:
| Title: | NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. |
|---|---|
| Authors: | Laskin, J.1 jlaskin@bccancer.bc.ca, Liu, S.V.1,2, Tolba, K.3, Heining, C.4,5,6, Schlenk, R.F.7, Cheema, P.8, Cadranel, J.9, Jones, M.R.10, Drilon, A.11, Cseh, A.12, Gyorffy, S.13, Solca, F.14, Duruisseaux, M.15 |
| Source: | Annals of Oncology. Dec2020, Vol. 31 Issue 12, p1693-1703. 11p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!